Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PERRIGO COMPANY PLC

(PRGO)
  Report
Delayed Nyse  -  04:00 2022-12-09 pm EST
31.55 USD   -1.77%
12/02Reckitt expects U.S. infant formula shortage until spring
RE
12/02U.S. infant formula shortage to drag on - Reckitt
RE
12/01Reckitt expects U.S. infant formula shortage until spring
RE
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nyse
12/05/2022 12/06/2022 12/07/2022 12/08/2022 12/09/2022 Date
31.81(c) 31.73(c) 31.61(c) 32.12(c) 31.55 Last
898 278 1 666 725 1 969 193 1 125 483 662 899 Volume
-0.41% -0.25% -0.38% +1.61% -1.77% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 4 516 M - -
Net income 2022 - - -
Net Debt 2022 3 528 M - -
P/E ratio 2022 -
Yield 2022 3,36%
Sales 2023 4 794 M - -
Net income 2023 16,5  - -
Net Debt 2023 3 244 M - -
P/E ratio 2023 263x
Yield 2023 3,70%
Capitalization 4 248 M 4 248 M -
EV / Sales 2022 1,72x
EV / Sales 2023 1,56x
Nbr of Employees 9 900
Free-Float 99,0%
More Financials
Company
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract... 
Sector
Pharmaceuticals
Calendar
03/02Earnings Release
More about the company
Ratings of Perrigo Company plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about PERRIGO COMPANY PLC
12/02Reckitt expects U.S. infant formula shortage until spring
RE
12/02U.S. infant formula shortage to drag on - Reckitt
RE
12/01Reckitt expects U.S. infant formula shortage until spring
RE
12/01Enfamil maker Reckitt sees formula shortage continuing until Spring
RE
12/01PERRIGO COMPANY PLC : Ex-dividend day for
FA
11/09Raymond James Adjusts Price Target on Perrigo Company to $42 From $48, Maintains Outper..
MT
11/09Perrigo Reports Third Quarter Fiscal Year 2022 Financial Results From Continuing Operat..
AQ
11/08PERRIGO CO PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
11/08Sector Update: Health Care Stocks Gain Premarket Tuesday
MT
11/08Transcript : Perrigo Company plc, Q3 2022 Earnings Call, Nov 08, 2022
CI
11/08Perrigo Reports Higher Fiscal Q3 Adjusted Profit, Net Sales; Cuts Fiscal 2022 Adjusted ..
MT
11/08Perrigo : Q3 Earnings Snapshot
AQ
11/08Perrigo Company plc Reports Earnings Results for the Third Quarter and Nine Months Ende..
CI
11/08Perrigo Company plc Reiterates Earnings Guidance for the Fiscal Year 2022
CI
11/08Earnings Flash (PRGO) PERRIGO COMPANY Reports Q3 Revenue $1.10B, vs. Street Est of $1.1..
MT
More news
News in other languages on PERRIGO COMPANY PLC
11/08Mise à jour sectorielle : Les actions du secteur de la santé gag..
11/08Perrigo annonce une hausse de son bénéfice ajusté et de ses ventes nettes au troisième ..
11/08Perrigo Company plc annonce ses résultats pour le troisième trimestre et les neuf mois ..
11/08Perrigo Company plc fournit des prévisions de bénéfices pour l'exercice 2022
11/03Perrigo Company plc annonce un dividende trimestriel, payable le 20 décembre 2022
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
ETFs positioned on PERRIGO COMPANY PLCETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
AGFiQ US Market Neutral Anti-Beta Fund - USD18.67%1.60%United_States
Rize Medical Cannabis and Life Sciences Acc - USD6.6%-4.16%-World
SPDR S&P Pharmaceuticals ETF - USD3.36%-1.28%United_States
Invesco Dynamic Pharmaceuticals ETF - USD3.19%-0.94%United_States
VanEck Vectors Pharmaceutical ETF - USD1.15%-0.60%United_States
More ETFs positioned on PERRIGO COMPANY PLC
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 31,55 $
Average target price 49,25 $
Spread / Average Target 56,1%
EPS Revisions
Managers and Directors
Murray S. Kessler President, Chief Executive Officer & Director
Eduardo Guarita Bezerra Chief Financial Officer & Executive Vice President
Orlando D. Ashford Chairman
Thomas M. Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PERRIGO COMPANY PLC-18.89%4 325
JOHNSON & JOHNSON2.73%463 286
ELI LILLY AND COMPANY34.60%353 267
ABBVIE INC.20.43%293 450
PFIZER, INC.-12.31%290 657
NOVO NORDISK A/S22.08%287 434